 ESSA Pharma Inc. Nasdaq: EPIX; TSX-V: EPI; ESSA or the Company, a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer announced the Company will be presenting at the Jefferies Virtual Healthcare Conference on Thursday June 4, 2020 at 3:30pm Eastern. 